Burden of Hospitalizations in Four Adolescent and Young Adult Cancer Survivor Populations in the United States, 2006 to 2020
Authors:
- Karen J. WernliKWKaren J. Wernli
- Eric C. HauptEHEric C. Haupt
- Andrew B. SmithermanASAndrew B. Smitherman
- Thearis OsujiTOThearis Osuji
- Ernest ShenESErnest Shen
- Neetu ChawlaNCNeetu Chawla
- Mallory CaspersonMCMallory Casperson
- Anne C. KirchhoffAKAnne C. Kirchhoff
- Cecile A. LaurentCLCecile A. Laurent
- Kathryn J. RuddyKRKathryn J. Ruddy
- Theresa H.M. KeeganTKTheresa H.M. Keegan
- Heydon K. KaddasHKHeydon K. Kaddas
- 11 November 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- p. OF1-OF9
Abstract
Background: We describe hospitalization rates in adolescent and young adult (AYA) cancer survivors 2 to 5 years (Y2–Y5) from diagnosis. Methods: Observational study of AYA cancer survivors diagnosed 2006 to 2020 was conducted in two healthcare systems [Kaiser Permanente Southern California (KPSC; n = 7,889) and Kaiser Permanente Northern California (KPNC; n = 7,338)] and two states [California (47,302) and Utah (n = 7,935)]. Hospitalizations were ascertained from electronic health records and statewide administrative records and stratified into pregnancy-related and other indications. Hospitalization rates were calculated by cohort. We estimated patient factors associated with hospitalizations using a Poisson model. Results: Most AYA survivors were women (∼64% of all cohorts), with a mean age of ∼31 years at diagnosis, and were predominantly non-Hispanic White (range, 35.1%–81.2%) or Hispanic (range, 14.3%–40.6%). Overall, 21% to 24% of AYA survivors experienced ≥1 hospitalization. Unadjusted hospitalization rates declined from Y2 [range, 155.1–243.4 per 1,000 person-years (PY)] to Y5 (range, 105.8–132.0 PY; P trend < 0.0001 in all cohorts). Factors associated with increased non–pregnancy-related hospitalizations were [range of relative risks (RR)] non-Hispanic Black race/ethnicity (RR, 1.46–1.66 vs. non-Hispanic White); public insurance (RR, 1.57–1.93 vs. commercial/military); receipt of chemotherapy (RR, 1.51–1.81); and cancer type—breast cancer (RR, 1.69–1.97), cervical cancer (RR, 2.30–3.31), colorectal cancer (RR, 2.76–3.66), acute lymphoblastic leukemia (ALL; RR, 2.89–5.19), acute myeloid leukemia (AML; RR, 2.11–5.05), and sarcoma (RR, 2.70–4.96; all vs. thyroid). Conclusions: Although hospitalizations decline as the time from diagnosis elapses across health system settings and states, nearly one in five AYA cancer survivors experience hospitalization in early survivorship. Impact: Hospitalization rates remain elevated in some AYA patient subgroups in early survivorship, highlighting the need to identify AYAs at risk to mitigate unanticipated hospitalizations and costs.Keywords
Funding Information
- National Cancer Institute (P01CA233432)